Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Zhang, M ^b   Liu, X ^b   Li, Jing ^a   He, L ^b   Tripathy, D ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

*Phytotherapy; Antineoplastic agents *adverse effects ; Breast neoplasms *drug therapy ; Drugs, Chinese herbal *therapeutic use ; Female; Humans; Randomized controlled trials as topic

Indexed keywords

AIDI; AIFUKANG; ANTINEOPLASTIC AGENT; BATILOL; CD3 ANTIGEN; CHINESE DRUG; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ERXIAN DAN; FLUOROURACIL; FUZHENG SHENG XUE TIAO YUAN TANG; HUANG QI; JIAWEI GUILU ERXIAN DAN; METHOTREXATE; NAVELBINE; PIRARUBICIN; PISHENTANG; PLATINUM COMPLEX; SHENMAI; SHENQI FUZHENG; XIANMAO; YIQIYANXUE;

ALOPECIA; ANEMIA; BONE MARROW SUPPRESSION; BREAST CANCER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONJUNCTIVITIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EMBASE; ENTERITIS; FATIGUE; HEART FAILURE; HUMAN; INFECTION; LEUKEMIA; LIVER TOXICITY; MEDLINE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PHLEBITIS; PREMATURE OVARIAN FAILURE; PROCTITIS; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SPLEEN DISEASE; STOMATITIS; THROMBOCYTOPENIA; VAGINITIS; VOMITING; WEIGHT GAIN;

EID: 34548624310     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004921.pub2     Document Type: Review

References (48)

1. Fang 1995 {published data only} ** Fang CL. Chinese herbs in the treatment of 30 breast cancer patients caused by postoperative chemotherapy. Journal of Traditional Chinese Medicine 1995;36(2):115.
2. Hong 2005 {published data only} **Hong SZ, Lin Y, Situ HL. A clinical study of Jiawei Guilin Erxian Dan for bone marrow inhibition in mammary cancer after chemotherapy. New Journal of Traditional Chinese Medicine 2005;37(1):32-3.
3. Huo 2003 {published data only} Huo J, Chen YP, Zhang DY. Shenmai injections for leukocytopenia reduction caused by chemotherapy for 26 breast cancer patients. Chinese Journal of Science and Technology of Traditional Chinese Medicine 2003;10(3):178.
4. Li 2002 {published data only} Li XL, Tian QY, Ma WJ.Clinical study on Shenqi Fuzheng injections combined with chemotherapy for advanced breast cancer patients. Chinese Practical Medical Journal 2002;2(24):2263-4.
5. Liu 2000 {published data only} Liu P, Cao YM, Qiao XM, Yang DQ, Zhou B, Shao H. Clinical study on Shenmai injections in promoting postoperative recovery in patients with breast cancer. Chinese Journal of Integrated Traditional and Western Medicine 2000;20(5):328-9.
6. Situ 2005 {published data only} Situ HL, Lin Y, Chen QJ, Ou AH, Zhu HY, Liu PX, et.al. Effect of Aifukang on quality of life of breast cancer patients treated with chemotherapy after operation. Journal of Guangzhou University of Traditional Chinese Medicine 2005;22(1):26-9.
7. Yang 2004 {published data only} **Yang L. Clinical study on Aidi injections combined with chemotherapy for advanced cancer patients. Chinese Journal of Integrated Traditional and Western Medicine 2004;24(8):755-6.
8. Hou 2000 Hou W, Zhang ZZ, Yan HF, Lu WP, Dong HT, Huo YH, Yang ZY. et.al. Chinese medicine Arduola Fuzhengling for the treatment of leukocytopenia reduction caused by chemotherapy for 45 breast cancer patients. Chinese Journal of Folk Therapy 2000;7:42-4.
9. Huang 2003 **Huang ZF, Ni HZ, Shi ZY, Zhong K. Xiaoyao Shan formula combined with chemotherapy in the treatment of 32 breast cancer patients. Chinese Archives of Traditional Chinese Medicine 2003;21(6):1001-17.
10. Li 2000 Li J, Ni XQ, Li JB, Liang QH, Yuan J, Tang LL. The influence of Fuzheng baozhentang decoction on the quality life of cancer patients with radiotherapy and chemotherapy. Journal of Zhenjiang College of Traditional Chinese Medicine 2000;24(3):23-5.
11. Liang 1999 Liang YJ. Clinical study on Shenqi fuzheng injections for advanced malignant tumour. Journal of Changchuan College of Traditional Chinese Medicine 1999;15(6):22.
12. Wang 1990 Wang Q, He SJ. Traditional Chinese medicine with western medicine in the treatment of 31 breast cancer patients. Cancer 1990;9(3):238-9.
13. Wang 2003 Wang GX, Cui ZM. Observation of Bazhentang decoction in the treatment of leukocytopenia caused by postoperative chemotherapy of breast carcinoma. Heibei Journal of Traditional Chinese Medicine 2003;25(1):10-2.
14. Weng 2003 Weng YQ, Tang HJ, Cheng AQ, Tang JX, Cheng YY, Li X. Clinical observation of health-supporting and pathogen-eliminating therapy for toxic and negative effects following chemotherapy in treating breast cancer. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologlaeque Shanghai 2003;17(3):28-31.
15. Wu 1997 Wu FX, Xia LM, Wang SY. Yiqibixietang decoction for leucocyte reduction caused by chemotherapy in 38 patients. Journal of Anhui College of Traditional Chinese Medicine 1997;16(2):24-25.
16. Yuan 1997 Yuan ZJ, Ouyang SX, Zheng SY. Integrated traditional Chinese with western medicine for leucocyte reduction of malignant tumour by chemotherapy in 58 patients. Huan Journal of Traditional Chinese Medicine 1997;13(4):32-3.
17. Zhang 1997 Zhang YZ, Xue DL. Clinical study on Pishentang decoction combined with chemotherapy in the treatment of 30 breast cancer patients. Chinese Journal of Integrated Traditional and Western Medicine 1997;17(10):632-3.
18. Aaronson 1993 Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et, al. The European Organization for Research and on Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Instituteion 1993;85:365-76. Journal of National Cancer Institution 1993;85:365-76.
19. Alderson 2004 Alderson P, Green S, Higgins JPT. Cochrane Revewers' Handbook 4.2.2 (updated December 2003). Cochrane Database of Systematic Reviews 2004, Issue Issue I.
20. Andrew 1999 Andrew V, Catherine Z. ABC of complementary medicine:Herbal medicine. BMJ 1999;319(7216):1050-3.
21. Berger 1998 Berger AM. Patterns of fatigue and activity and rest during adjunctive breast cancer chemotherapy. Oncology Nursing Forum 1998;25(51):51-2.
22. Bower 2000 Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: correlates, and impact on quality of life. Journal of Clinical Oncology 2000;18(4):743-53.
23. Broeckel 1998 Broeckel JA, Jacobosen PB, Horton J, Balducci L, Lyman CH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 1998;16(5):1689- 96.
24. Campora 1994 Campora E, Merlini L, Rubagotti A, Rosso R. Ondansetron and dexamethasone versus standard combination antiemetic therapy: A randomised trial for prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect. American Journal of Clinical Oncology 1994;17(6):522-6.
25. Clarke 2000 Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook included in 4.1Review Manager(RevMan). Computer program Version 4.1. The Cochrane Collaboration, Updated June 2000.
26. Cohen 2002 Cohen I, Tagliaferri M, Tripathy D. Tradional Chinese medicine in the treatment of breast cancer. Seminars in Oncology 2002;29(6):563-74.
27. Crawford 2003 Crawford J, Dale CD, Lyman GH. Chemotherapy -induced neutropenia. Cancer 2004;100(2):228-37.
28. Cunningham 1997 Cunningham RS. 5-HT3 receptor antagonists: A review of pharmacology and clinical efficacy. Oncology Nursing Forum 1997;24(Suppl 7):33-4.
29. EBCTCG 2005 Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-717.
30. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34.
31. Fulder 1996 Fulder S. The handbook of alternative and complementary medicine. Oxford: Oxford University Press, 1996.
32. Gralla 2002 Gralla RJ. New agents, new treatment, and antiemetic therapy. Seminars in Oncology Feb. 2002;29(Suppl 4):119-24.
33. Hayes 1995 Hayes DF, Henderson IC, Shapiro CL. Treatment of metastatic breast cancer : Present and future prospects. Seminars in Oncology 1995;22(Suppl 5):5-21.
34. Hudis 2005 Hudis CA, Vogel CL, Cralow JR, Williams D, Procrit Study Group. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. Clinical Breast Cancer 2005;6(2):132-42.
35. King 1997 King CR. Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum 1997;24(Suppl 7):41-8.
36. Kirby 1997 Kirby AJ, Schmidt RJ. The antioxidant activity of Chinese herbs for eczema and of placebo herbs. Journal of Ethnopharmacology 1997;56(2):103-8.
37. Kris 2006 American Society of Clinical Oncology, Kris MG, Hesketh PJ, Somerfield MR, Fever P, Clark-Snow R, Koeller JM, et al.American Society of Clinical Oncology guideline for antiemetics in oncology. Journal of Clinical Oncology update 2006;24(18):2932-47.
38. Liu 2002 Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database of Systematic Reviews 2002, Issue 2.Art. No.: CD001940. DOI:10.1002/14651858.CD001940.
39. Liu 2006 JP Liu, M Yang, YX Liu, ML Wei, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2006, Issue Issue 1.Art. No.: CD004116. DOI:10.1002/14651858.CD004116.pub2.
40. Partridge 2001 Partridge AH, Burstein Harold HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. Journal of the National Cancer Institute Monographs 2001;30:132-42.
41. Pico 1998 Pico JL, Avila-Garavito A, Naccache P. Mucositis: Its occurrence, consequences, and treatment in oncology the setting. The Oncologist 1998;3(6):446-51.
42. Ramalingam 2002 Ramalingam S. Belani CP. Meaning survival in lung cancer patients. Seminars in Oncology 2002;29(1Suppl):125-31.
43. Schulz 1995 Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. Journal of the American Medical Association 1995;273(5):408-12.
44. Sitzia 1998 Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Practice 1998;6(1):13-21.
45. Stasi 2003 Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. Cancer-related fatigue. Cancer 2003;98(9):1786-1800.
46. Sun 2002 Sun SP. The development of traditional Chinese medicine in treatment of breast cancer. Chinese Journal of Surgery of Integrated Traditional and Western Medicine 2002;8(6):455-7.
47. Watson 1992 Watson M, Law M, Maguire GP, Robertson B, Greer S, Bliss JM, et al.Further development of a quality of life measure for cancer patients: The Rotterdam Symptom Checklist (Revised). Psychooncology 1992;1:35-44.
48. Zhang 2002 Zhang WB, Wang B, Shi LC. An application of traditional Chinese medicine in the treatment of breast cancer patients. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2002;9(1):54-5.